Skip to main content

Advertisement

Table 2 Cox regression analysis of the main covariates of the time to systemic therapy form study entry for all analysed patients

From: [18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results

  B SE Wald df Sig. HR HR 95,0 % CI
Lower Upper
Age 0,11 0,06 3,56 1,00 0,06 1,12 1,00 1,25
Delta_PSA 0,00 0,00 4,50 1,00 0,03* 1,00 1,00 1,01
Castration Resistant 0,37 0,67 0,31 1,00 0,58 1,45 0,39 5,45
Gleason Score −0,83 0,51 2,65 1,00 0,10 0,44 0,16 1,19
Metastasis (lynph node, bone, both) −0,47 0,64 0,54 1,00 0,46 0,63 0,18 2,18
Doubling time (months) 0,00 0,02 0,01 1,00 0,91 1,00 0,96 1,05
Clinical target volume (CTV) 0.16 0.01 0.27 1,00 0.1 1,18 0,97 1,42
Cirs com −1,12 0,70 2,57 1,00 0,11 0,33 0,08 1,28
Cirs sev −3,20 2,67 1,44 1,00 0,23 0,04 0,00 7,66
  1. *Delta PSA value resulted significant in the univariate analysis while it did not after adjusting for the age